HK1127289A1 - Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol - Google Patents

Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol

Info

Publication number
HK1127289A1
HK1127289A1 HK09105733.2A HK09105733A HK1127289A1 HK 1127289 A1 HK1127289 A1 HK 1127289A1 HK 09105733 A HK09105733 A HK 09105733A HK 1127289 A1 HK1127289 A1 HK 1127289A1
Authority
HK
Hong Kong
Prior art keywords
paracetamol
dimethylamino
phenol
propyl
ethyl
Prior art date
Application number
HK09105733.2A
Other languages
English (en)
Inventor
Petra Bloms-Funke
Klaus Schiene
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37025148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1127289(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of HK1127289A1 publication Critical patent/HK1127289A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HK09105733.2A 2006-04-28 2009-06-25 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol HK1127289A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06008851 2006-04-28
PCT/EP2007/003632 WO2007128413A1 (en) 2006-04-28 2007-04-25 Pharmaceutical combination comprising 3- ( 3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol

Publications (1)

Publication Number Publication Date
HK1127289A1 true HK1127289A1 (en) 2009-09-25

Family

ID=37025148

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09105733.2A HK1127289A1 (en) 2006-04-28 2009-06-25 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol

Country Status (25)

Country Link
EP (1) EP2012764B1 (xx)
JP (2) JP5496653B2 (xx)
KR (1) KR101396166B1 (xx)
CN (1) CN101431990B (xx)
AT (1) ATE494889T1 (xx)
AU (1) AU2007247481B2 (xx)
BR (1) BRPI0710682B8 (xx)
CA (1) CA2650423C (xx)
CY (1) CY1111369T1 (xx)
DE (1) DE602007011913D1 (xx)
DK (1) DK2012764T3 (xx)
EC (2) ECSP088793A (xx)
ES (1) ES2356093T3 (xx)
HK (1) HK1127289A1 (xx)
HR (1) HRP20110076T1 (xx)
IL (1) IL194883A (xx)
MX (1) MX2008013779A (xx)
NO (2) NO341602B1 (xx)
NZ (1) NZ571442A (xx)
PL (1) PL2012764T3 (xx)
PT (1) PT2012764E (xx)
RU (1) RU2442576C2 (xx)
SI (1) SI2012764T1 (xx)
WO (1) WO2007128413A1 (xx)
ZA (1) ZA200810124B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007012165A1 (de) 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
KR101784777B1 (ko) * 2007-11-23 2017-11-06 그뤼넨탈 게엠베하 타펜타돌 조성물
PL2582366T3 (pl) 2010-06-15 2016-04-29 Gruenenthal Gmbh Kombinacja farmaceutyczna do leczenia bólu
MX344473B (es) 2011-03-04 2016-12-16 Gruenenthal Gmbh Composicion farmaceutica acuosa semisolida que contiene tapentadol.
LT2680832T (lt) 2011-03-04 2019-10-25 Gruenenthal Gmbh Tapentadolio vandeninė farmacinė kompozicija, skirta vartoti geriant
RS54711B1 (en) * 2011-03-04 2016-08-31 Grünenthal GmbH PARENTERAL TAPENTADOL ADMINISTRATION
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
PT3479823T (pt) 2015-03-27 2020-09-29 Gruenenthal Gmbh Formulação estável para administração parentérica de tapentadol
KR20190057349A (ko) 2016-09-23 2019-05-28 그뤼넨탈 게엠베하 타펜타돌의 비경구 투여용 안정한 제제
WO2018153947A1 (en) 2017-02-23 2018-08-30 Grünenthal GmbH Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
PT1562567T (pt) 2002-11-22 2017-08-24 Gruenenthal Gmbh Combinação de analgésicos selecionados e inibidores da cox-ii

Also Published As

Publication number Publication date
RU2008146816A (ru) 2010-06-10
MX2008013779A (es) 2008-11-14
BRPI0710682A2 (pt) 2011-08-23
NO20171831A1 (no) 2008-10-28
DE602007011913D1 (de) 2011-02-24
RU2442576C2 (ru) 2012-02-20
ECSP088793A (es) 2008-11-27
CA2650423A1 (en) 2007-11-15
HRP20110076T1 (hr) 2011-02-28
SI2012764T1 (sl) 2011-03-31
CN101431990A (zh) 2009-05-13
ATE494889T1 (de) 2011-01-15
NO343505B1 (no) 2019-03-25
AU2007247481A1 (en) 2007-11-15
PT2012764E (pt) 2011-02-02
JP2013213045A (ja) 2013-10-17
AU2007247481B2 (en) 2013-02-14
JP5496653B2 (ja) 2014-05-21
NO341602B1 (no) 2017-12-11
BRPI0710682B8 (pt) 2021-05-25
NO20084542L (no) 2008-10-28
BRPI0710682B1 (pt) 2020-09-24
CA2650423C (en) 2014-08-12
CY1111369T1 (el) 2015-08-05
ES2356093T3 (es) 2011-04-04
EP2012764A1 (en) 2009-01-14
NZ571442A (en) 2011-09-30
EP2012764B1 (en) 2011-01-12
JP2009535313A (ja) 2009-10-01
ZA200810124B (en) 2009-08-26
KR101396166B1 (ko) 2014-05-27
DK2012764T3 (da) 2011-02-28
ECSP17000643A (es) 2018-06-30
IL194883A0 (en) 2009-08-03
IL194883A (en) 2012-10-31
PL2012764T3 (pl) 2011-04-29
WO2007128413A1 (en) 2007-11-15
KR20090006219A (ko) 2009-01-14
CN101431990B (zh) 2011-08-03

Similar Documents

Publication Publication Date Title
ECSP17000643A (es) Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol.
MX2008013828A (es) Combinacion farmaceutica que comprende 3-(3-dimetilanimo-1-etil-2- metil-propil)-fenol y un nsaid.
WO2010025931A3 (en) Pharmaceutical combination of 3- (3-dimethylamino-1-ethyl-2 -methyl-propyl) - phenol and an antiepileptic
AU2016219643A1 (en) Pharmaceutical combination for the treatment of pain
WO2007143607A3 (en) Method of treating atrophic vaginitis
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2013158680A3 (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
WO2011099832A3 (en) Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
BRPI0922789A2 (pt) peptídeo de ligação de albumina intermediador para reconhecimento de doença
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
HK1176318A1 (en) Injection device
WO2007056236A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
WO2008012796A3 (en) Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
TW200744676A (en) Pharmaceutical compositions for the eradication of helicobacter pylori
WO2007084383A3 (en) Method and composition for the treatment of parkinson's disease
WO2014170820A3 (en) A pharmaceutical combination for treating tuberculosis